Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000921895-22-002055

Options or other derivatives

  • Director acquired 12,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ma-Weaver Jacob · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-15 Grant or award : show line 1 in the form Stock Option (right to buy) +12,000 12,000 D
Loading xslF345X03/form413392002_06212022.xml…